Apoptotic osteocytes and the control of targeted bone resorption

Current Osteoporosis Reports

Volumn 12, Issue 1, 2014, Pages 121-126

  Plotkin, Lilian I ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Bone remodeling; Osteocyte

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CONNEXIN 43; INTERLEUKIN 6; MATRIX METALLOPROTEINASE; MONOCYTE CHEMOTACTIC PROTEIN 1; OSTEOCLAST DIFFERENTIATION FACTOR; PARATHYROID HORMONE; PROTEIN BCL 2; PROTEIN P53; PROTEIN P66; SOMATOMEDIN C; TRANSCRIPTION FACTOR RUNX2;

APOPTOSIS; BONE MASS; BONE NECROSIS; BONE REMODELING; CELL DAMAGE; CELL SURVIVAL; CELLULAR DISTRIBUTION; DRUG EFFICACY; DRUG RESPONSE; HUMAN; NONHUMAN; OSTEOBLAST; OSTEOCYTE; OSTEOLYSIS; OXIDATIVE STRESS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVIEW;

APOPTOSIS; BONE REMODELING; BONE RESORPTION; HUMANS; OSTEOCYTES; SIGNAL TRANSDUCTION;

EID: 84895927112     PISSN: 15441873     EISSN: 15442241     Source Type: Journal    
DOI: 10.1007/s11914-014-0194-3     Document Type: Review

References (61)

1. Bellido T. Osteocyte-driven bone remodeling. Calcif Tissue Int. 2013;94:25-34.
2. Noble BS, Reeve J. Osteocyte function, osteocyte death and bone fracture resistance. Mol Cell Endocrinol. 2000;159:7-13. (Pubitemid 30067635)
3. Frost HM. In vivo osteocyte death. J Bone Joint Surg Am. 1960;42-A:138-43.
4. Almeida M, Han L, Martin-Millan M, et al. Skeletal involution by age-associated oxidative stress and its acceleration by loss of sex steroids. J Biol Chem. 2007;282:27285-97. (Pubitemid 47501960)
5. TomkinsonA, Reeve J, Shaw RW, et al. The death of osteocytes via apoptosis accompanies estrogen withdrawal in human bone. J Clin Endocrinol Metab. 1997;82:3128-35. (Pubitemid 27385687)
6. Kousteni S, Bellido T, Plotkin LI, et al. Nongenotropic, sex-nonspecific signaling through the estrogen or androgen receptors: dissociation from transcriptional activity. Cell. 2001;104:719-30. (Pubitemid 32241022)
7. Weinstein RS, Jilka RL, Parfitt AM, et al. Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids: potential mechanisms of their deleterious effects on bone. J Clin Invest. 1998;102:274-82. (Pubitemid 28335186)
8. Aguirre JI, Plotkin LI, Stewart SA, et al. Osteocyte apoptosis is induced by weightlessness in mice and precedes osteoclast recruitment and bone loss. J Bone Miner Res. 2006;21:605-15.
9. Morse LR, Xu Y, Solomon B, et al. Severe spinal cord injury causes immediate multi-cellular dysfunction at the chondro-osseous junction. Transl Stroke Res. 2011;2:643-50.
10. Verborgt O, Gibson G, Schaffler MB. Loss of osteocyte integrity in association with microdamage and bone remodeling after fatigue in vivo. J Bone Miner Res. 2000;15:60-7. (Pubitemid 30026933)
11. Jilka RL, Weinstein RS, Bellido T, et al. Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone. J Clin Invest. 1999;104:439-46. (Pubitemid 29534328)
12. Plotkin LI, Weinstein RS, Parfitt AM, et al. Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin. J Clin Invest. 1999;104:1363-74.
13. Gohel A, McCarthy MB, Gronowicz G. Estrogen prevents glucocorticoid- induced apoptosis in osteoblasts in vivo and in vitro. Endocrinology. 1999;140:5339-47.
14. Manolagas SC, Parfitt AM. What old means to bone. Trends Endocrinol Metab. 2010;21:369-74.
15. Jilka RL, Bellido T, Almeida M, Plotkin LI, O'Brien CA, Weinstein RS, et al. Apoptosis in bone cells. In: Bilezikian JP, Raisz LG, Martin TJ, editors. Principles of bone biology. San Diego, San Francisco, New York, London, Sydney, Tokyo: Academic Press; 2008. p. 237-61.
16. .•• Jilka RL, O'Brien CA, Roberson PK, et al. Dysapoptosis of osteoblasts and osteocytes increases cancellous bone formation but exaggerates bone porositywith age. J Bone Miner Res. 2014;29:103-17. Reports the effect of preventing osteocyte apoptosis on gene expression and bone remodeling.
17. Weinstein RS, Nicholas RW, Manolagas SC. Apoptosis of osteocytes in glucocorticoid-induced osteonecrosis of the hip. J Clin Endocrinol Metab. 2000;85:2907-12. (Pubitemid 32269172)
18. Plotkin LI, Manolagas SC, Bellido T. Glucocorticoids induce osteocyte apoptosis by blocking focal adhesion kinase-mediated survival: evidence for inside-out signaling leading to anoikis. J Biol Chem. 2007;282:24120-30. (Pubitemid 47328056)
19. Canalis E, Delany AM. Mechanisms of glucocorticoid action in bone. Ann N YAcad Sci. 2002;966:73-81. (Pubitemid 34729163)
20. Wang FS, Lin CL, Chen YJ, et al. Secreted frizzled-related protein 1 (SFRP1) modulates glucocorticoid attenuation of osteogenic activities and bone mass. Endocrinology. 2005;146:2415-23.
21. Almeida M, Han L, Ambrogini E, et al. Glucocorticoids and tumor necrosis factor (TNF) alpha increase oxidative stress and suppress WNT signaling in osteoblasts. J Biol Chem. 2011;286:44326-35.
22. Jia J, Yao W, Guan M, et al. Glucocorticoid dose determines osteocyte cell fate. FASEB J. 2011;25:3366-76.
23. Weinstein RS, Wan C, Liu Q, et al. Endogenous glucocorticoids decrease skeletal angiogenesis, vascularity, hydration, and strength in 21-month-old mice. Aging Cell. 2009;9:147-61.
24. Noble BS, Peet N, Stevens HY, et al. Mechanical loading: biphasic osteocyte survival and the targeting of osteoclasts for bone destruction in rat cortical bone. Am J Physiol Cell Physiol. 2003;284:C934-43. (Pubitemid 36336949)
25. Lin C, Jiang X, Dai Z, et al. Sclerostin mediates bone response to mechanical unloading through antagonizing Wnt/beta-catenin signaling. J Bone Miner Res. 2009;24:1651-61.
26. Verborgt O, Tatton NA, Majeska RJ, et al. Spatial distribution of Bax and Bcl-2 in osteocytes after bone fatigue: complementary roles in bone remodeling regulation? J Bone Miner Res. 2002;17:907-14. (Pubitemid 34441908)
27. Bellido T, Ali AA, Plotkin LI, et al. Proteasomal degradation of Runx2 shortens parathyroid hormone-induced anti-apoptotic signaling in osteoblasts. A putative explanation for why intermittent administration is needed for bone anabolism. J Biol Chem. 2003;278:50259-72. (Pubitemid 37548867)
28. Bivi N, Lezcano V, Romanello M, et al. Connexin43 interacts with barrestin: a prerequisite for osteoblast survival induced by parathyroid hormone. J Cell Biochem. 2011;112:2920-30.
29. Rogers MJ, Crockett JC, Coxon FP, et al. Biochemical and molecular mechanisms of action of bisphosphonates. Bone. 2011;49:34-41.
30. Plotkin LI, Manolagas SC, Bellido T. Transduction of cell survival signals by connexin-43 hemichannels. J Biol Chem. 2002;277:8648-57. (Pubitemid 34968331)
31. Plotkin LI, Lezcano V, Thostenson J, et al. Connexin 43 is required for the anti-apoptotic effect of bisphosphonates on osteocytes and osteoblasts in vivo. J Bone Miner Res. 2008;23:1712-21.
32. Plotkin LI, Bivi N, Bellido T. A bisphosphonate that does not affect osteoclasts prevents osteoblast and osteocyte apoptosis and the loss of bone strength induced by glucocorticoids in mice. Bone. 2011;49:122-7.
33. Plotkin LI, Aguirre JI, Kousteni S, et al. Bisphosphonates and estrogens inhibit osteocyte apoptosis via distinct molecular mechanisms downstream of ERK activation. J Biol Chem. 2005;280:7317-25. (Pubitemid 40341290)
34. Plotkin LI, Manolagas SC, Bellido T. Dissociation of the proapoptotic effects of bisphosphonates on osteoclasts from their anti-apoptotic effects on osteoblasts/osteocytes with novel analogs. Bone. 2006;39:443-52. (Pubitemid 44164640)
35. Tomkinson A, Gevers EF, Wit JM, et al. The role of estrogen in the control of rat osteocyte apoptosis. J Bone Miner Res. 1998;13:1243-50. (Pubitemid 28373325)
36. Kousteni S, Chen JR, Bellido T, et al. Reversal of bone loss in mice by nongenotropic signaling of sex steroids. Science. 2002;298:843-6. (Pubitemid 35231540)
37. Huber C, Collishaw S, Mosley JR, et al. Selective estrogen receptor modulator inhibits osteocyte apoptosis during abrupt estrogen withdrawal: implications for bone quality maintenance. Calcif Tissue Int. 2007;81:139-44. (Pubitemid 47228736)
38. Kousteni S, Han L, Chen JR, et al. Kinase-mediated regulation of common transcription factors accounts for the bone-protective effects of sex steroids. J Clin Invest. 2003;111:1651-64. (Pubitemid 38057747)
39. van Essen HW, Holzmann PJ, Blankenstein MA, et al. Effect of raloxifene treatment on osteocyte apoptosis in postmenopausal women. Calcif Tissue Int. 2007;81:183-90. (Pubitemid 47373354)
40. Plotkin LI, Mathov I, Aguirre JI, et al. Mechanical stimulation prevents osteocyte apoptosis: requirement of integrins, Src kinases, and ERKs. Am J Physiol Cell Physiol. 2005;289:C633-43. (Pubitemid 41192673)
41. Aguirre JI, Plotkin LI, Gortazar AR, et al. A novel ligand-independent function of the estrogen receptor is essential for osteocyte and osteoblast mechanotransduction. J Biol Chem. 2007;282:25501-8. (Pubitemid 47372838)
42. Kitase Y, Barragan L, Jiang JX, et al. Mechanical induction of PGE(2) in osteocytes blocks glucocorticoid induced apoptosis through both the beta-catenin and PKA pathways. J Bone Miner Res. 2010;25:2657-68.
43. Frost HM. Bone's mechanostat: a 2003 update. Anat Rec. 2003;275A:1081-101. (Pubitemid 37486785)
44. Noble BS, Stevens H, Loveridge N, et al. Identification of apoptotic changes in osteocytes in normal and pathological human bone. Bone. 1997;20:273-82. (Pubitemid 27141840)
45. Elmardi AS, Katchburian MV, Katchburian E. Electron microscopy of developing calvaria reveals images that suggest that osteoclasts engulf and destroy osteocytes during bone resorption. Calcif Tissue Int. 1990;46:239-45. (Pubitemid 20142831)
46. Boabaid F, Cerri PS, Katchburian E. Apoptotic bone cells may be engulfed by osteoclasts during alveolar bone resorption in young rats. Tissue Cell. 2001;33:318-25.
47. Cerri PS, Boabaid F, Katchburian E. Combined TUNEL and TRAP methods suggest that apoptotic bone cells are inside vacuoles of alveolar bone osteoclasts in young rats. J Periodontal Res. 2003;38:223-6. (Pubitemid 37485623)
48. Cardoso L, Herman BC, Verborgt O, et al. Osteocyte apoptosis controls activation of intracortical resorption in response to bone fatigue. J Bone Miner Res. 2009;24:597-605.
49. Emerton KB, Hu B, Woo AA, et al. Osteocyte apoptosis and control of bone resorption following ovariectomy in mice. Bone. 2009;46:577-83.
50. Tatsumi S, Ishii K, Amizuka N, et al. Targeted ablation of osteocytes induces osteoporosis with defective mechanotransduction. Cell Metab. 2007;5:464-75. (Pubitemid 46825494)
51. Bivi N, Condon KW, Allen MR, et al. Cell autonomous requirement of connexin 43 for osteocyte survival: consequences for endocortical resorption and periosteal bone formation. J Bone Miner Res. 2012;27:374-89.
52. Lloyd SA, Loiselle AE, Zhang Y, et al. Connexin 43 deficiency desensitizes bone to the effects of mechanical unloading through modulation of both arms of bone remodeling. Bone. 2013;57:76-83.
53. Schaffler MB, Cheung WY, Majeska R, et al. Osteocytes: master orchestrators of bone. Calcif Tissue Int. 2013;94:5-24.
54. .• Kennedy OD, Herman BC, Laudier DM, et al. Activation of resorption in fatigue-loaded bone involves both apoptosis and active pro-osteoclastogenic signaling by distinct osteocyte populations. Bone. 2012;50:1115-22. Reports the temporal relationships between injury, osteocyte apoptosis, and pro-osteoclastogenic signaling following excess loading.
55. Wu AC, Morrison NA, Kelly WL, et al. MCP-1 expression is specifically regulated during activation of skeletal repair and remodeling. Calcif Tissue Int. 2013;92:566-75.
56. Zhang Y, Paul EM, Sathyendra V, et al. Enhanced osteoclastic resorption and responsiveness to mechanical load in gap junction deficient bone. PLoS One. 2011;6:e23516.
57. Kogianni G, Mann V, Noble BS. Apoptotic bodies convey activity capable of initiating osteoclastogenesis and localized bone destruction. J Bone Miner Res. 2008;23:915-27. (Pubitemid 351768810)
58. Yang J, Shah R, Robling AG, et al. HMGB1 is a bone-active cytokine. J Cell Physiol. 2008;214:730-9. (Pubitemid 351224218)
59. Klune JR, Dhupar R, Cardinal J, et al. HMGB1: endogenous danger signaling. Mol Med. 2008;14:476-84.
60. Zhou Z, Han JY, Xi CX, et al. HMGB1 regulates RANKL-induced osteoclastogenesis in a manner dependent on RAGE. J Bone Miner Res. 2008;23:1084-96. (Pubitemid 351915731)
61. Taniguchi N, Yoshida K, Ito T, et al. Stage-specific secretion of HMGB1 in cartilage regulates endochondral ossification. Mol Cell Biol. 2007;27:5650-63. (Pubitemid 47257823)